Home - Tandem Meetings News

February 23, 2026

Plenary session delivers a master class on the future of AI in transplant and cell therapy

Speakers discuss the role of physician intuition, artificial intelligence’s impact in a high-throughput lab and other possible transformations.
February 23, 2026

Authors highlight cutting-edge science and research at Late Breaking Abstracts session

Naseem Esteghamat, MD, MS, and three other speakers present recent and impactful research on the final day of the Tandem Meetings.

MORE #TANDEM26 NEWS

February 23, 2026

Speakers share long-term efficacy and real-world outcomes for CAR T-therapies in lymphoma

Sairah Ahmed, MD, and other speakers discuss TRANSCEND FL, use of cfRNA in minimally invasive TME readouts and more
February 23, 2026

Panelists present four studies from the Blood & Marrow Transplant Clinical Trials Network

Speakers provide updates on ongoing, impactful studies: PROGRESS IV, 2207 CureAA, 2303 aGVHD Treatment and 2402 Non-Malignant Biorepository (HOPE).
February 23, 2026

Session reviews progress on initiatives for improving BMT clinical trial access

Two ongoing projects aim to reduce barriers to trials through help navigating the financial burdens patients face and multimodal education.

February 23, 2026

Claim your credits and certification points from the 2026 Tandem Meetings

Read details for deadlines, links to forms and information on qualifying sessions.
February 7, 2026

Plenary to explore diagnostic and therapeutic developments for MRD post-transplant

Ran Reshef, MD, MSc, previews a session about the high priority of eradicating disease and preventing relapse.
February 7, 2026

Pharmacist to discuss medical cannabis use among stem cell transplant patients

Kali Ditolla, PharmD, BCOP, shares safety considerations and recommendations for treating patients who use cannabis products.

MORE #TANDEM26 NEWS

February 23, 2026

Speakers share long-term efficacy and real-world outcomes for CAR T-therapies in lymphoma

Sairah Ahmed, MD, and other speakers discuss TRANSCEND FL, use of cfRNA in minimally invasive TME readouts and more
February 23, 2026

Panelists present four studies from the Blood & Marrow Transplant Clinical Trials Network

Speakers provide updates on ongoing, impactful studies: PROGRESS IV, 2207 CureAA, 2303 aGVHD Treatment and 2402 Non-Malignant Biorepository (HOPE).

February 23, 2026

Session reviews progress on initiatives for improving BMT clinical trial access

Two ongoing projects aim to reduce barriers to trials through help navigating the financial burdens patients face and multimodal education.
February 23, 2026

Claim your credits and certification points from the 2026 Tandem Meetings

Read details for deadlines, links to forms and information on qualifying sessions.

AWARD SPOTLIGHTS

AWARD SPOTLIGHTS

MEET-THE-PROFESSOR SPOTLIGHTS